pharmaphorum3 天
Mylan launches Advair generic at 70% discount in US
Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...
Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
pharmaphorum6 年
FDA finally approves Mylan's Advair generic
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...
Pfizer shares gain 9% after board approves agreement with Mylan Pharma
Under the agreement, the company with Mylan Pharma will market and sell two brands Ativan and Pacitane. The contract is for ...
India Infoline12 天
Pfizer Ties Up with Mylan to Boost Ativan and Pacitane Sales in India
Activan is prescribed for anxiety disorders, and Pacitane is used in treating Parkinson’s disease and other neurological ...
Regeneron wins injunction blocking Mylan from launching generic version of its eye drug ...
Regeneron (NASDAQ:REGN) won a permanent injunction that blocks drugmakers including, Mylan Pharmaceuticals/Biocon Biologics, ...
Pharmabiz21 天
Glenmark Pharmaceuticals introduces clindamycin phosphate foam, 1%
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark’s clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the ...